chr3-113291704-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_001164496.2(CFAP44):āc.5418A>Gā(p.Arg1806=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00255 in 1,536,908 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.0018 ( 0 hom., cov: 32)
Exomes š: 0.0026 ( 8 hom. )
Consequence
CFAP44
NM_001164496.2 synonymous
NM_001164496.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.417
Genes affected
CFAP44 (HGNC:25631): (cilia and flagella associated protein 44) Enables peptidase activity. Involved in sperm axoneme assembly. Acts upstream of or within microtubule cytoskeleton organization. Predicted to be located in cytoplasm; cytoskeleton; and motile cilium. Implicated in spermatogenic failure 20. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 3-113291704-T-C is Benign according to our data. Variant chr3-113291704-T-C is described in ClinVar as [Benign]. Clinvar id is 717618.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.417 with no splicing effect.
BS2
High Homozygotes in GnomAdExome4 at 8 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CFAP44 | NM_001164496.2 | c.5418A>G | p.Arg1806= | synonymous_variant | 35/35 | ENST00000393845.9 | |
LOC127898559 | NR_183046.1 | n.8054A>G | non_coding_transcript_exon_variant | 48/48 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CFAP44 | ENST00000393845.9 | c.5418A>G | p.Arg1806= | synonymous_variant | 35/35 | 5 | NM_001164496.2 | P2 | |
CFAP44 | ENST00000484923.1 | n.550A>G | non_coding_transcript_exon_variant | 2/2 | 4 | ||||
CFAP44 | ENST00000461734.1 | c.*108A>G | 3_prime_UTR_variant, NMD_transcript_variant | 10/10 | 2 | ||||
CFAP44 | ENST00000489244.1 | c.*341A>G | 3_prime_UTR_variant, NMD_transcript_variant | 4/4 | 5 |
Frequencies
GnomAD3 genomes AF: 0.00182 AC: 277AN: 152214Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
277
AN:
152214
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00186 AC: 271AN: 146068Hom.: 1 AF XY: 0.00184 AC XY: 143AN XY: 77616
GnomAD3 exomes
AF:
AC:
271
AN:
146068
Hom.:
AF XY:
AC XY:
143
AN XY:
77616
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00264 AC: 3649AN: 1384576Hom.: 8 Cov.: 34 AF XY: 0.00247 AC XY: 1687AN XY: 683196
GnomAD4 exome
AF:
AC:
3649
AN:
1384576
Hom.:
Cov.:
34
AF XY:
AC XY:
1687
AN XY:
683196
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00182 AC: 277AN: 152332Hom.: 0 Cov.: 32 AF XY: 0.00180 AC XY: 134AN XY: 74490
GnomAD4 genome
AF:
AC:
277
AN:
152332
Hom.:
Cov.:
32
AF XY:
AC XY:
134
AN XY:
74490
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
CFAP44-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 21, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at